A Real-World Study of Inavolisib in Patients With HR-Positive/HER2-Negative, PIK3CA-Mutated Advanced Breast Cancer
Clinical trial NCT07543250 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07543250
- Sponsor
- xuliang
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-05-16
- Primary completion
- 2026-12-31
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.